Drug-related morbidity and mortality and the economic impact of pharmaceutical care
Drug-related morbidity and mortality and the economic impact of pharmaceutical care
复制标题
DOI：
10.1093/ajhp/54.5.554
复制
发表时间：
1997-03-01
影响因子：
2.7
通讯作者：
Bootman, JL
中科院分区：
文献类型：
--
作者：
Johnson, JA;Bootman, JL
在美国为门诊病人提供药物治疗的经济影响。方法.先前已详细描述了用于估计与药物有关的发病率和死亡率的费用的模型的开发。[1]该概率途径模型（图1）主要基于在缺乏药学服务的情况下可能发生的药物相关问题和负面治疗结果。2，3模型中还包括了管理负面治疗结果所消耗的卫生保健资源。在模型中确定的药物治疗结果的条件概率由一组药剂师提供。
N nomic impact of providing pharmaceutical care to ambulatory care patients in the United States. Methods. The development of the model for estimating the cost of drug-related morbidity and mortality was previously described in detail. 1 This probability pathway model (Figure 1) was based primarily on the drug-related problems and negative therapeutic outcomes that may occur in the absence of pharmaceutical care. 2, 3 Health care resources that would be consumed in the management of negative therapeutic outcomes were also included in the model. Conditional probabilities for the outcomes of drug therapy identified in the model were provided by a panel of pharmacists.